FENC

MKT CAP:$338M

Fennec Pharmaceuticals Inc

Market Cap

$338M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$8.70+$1.02 (+13.28%)

Jun 5, 2026

52W High $9.9852W Low $5.77

Company Details

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxi...

CEO

—

IPO Date

Jun 5, 2001

Website

www.fennecpharma.com

Key Metrics TTM

Revenue

$51M

+65.0% YoY

Net Income

-$8M

EPS (Diluted)

Free Cash Flow

-$6M

Revenue / Share

$1.43

Gross Margin

92.2%

Operating Margin

-11.0%

Net Margin

-16.4%

FCF Margin

-11.3%

P/S

6.6x

P/E

Earnings Reports

Q1 2026

May 14, 2026

$15M+72.6%

FY 2025

Mar 27, 2026

$45M-6.1%

Q4 2025

Mar 27, 2026

$14M+73.8%

Q3 2025

Nov 13, 2025

$12M+78.7%

Q2 2025

Aug 14, 2025

$10M+32.9%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee